U.S. Markets open in 4 hrs 5 mins

Amedisys Ties Up With Medalogix to Boost Home Health Unit

Zacks Equity Research
1 / 2

Amedisys Ties Up With Medalogix to Boost Home Health Unit

Amedisys (AMED) pursues deals to boost Home Health business.

Amedisys, Inc. AMED recently announced a minority equity investment in Medalogix — a Home Health and Hospice predictive modeling and analytics company in Nashville.

Per Amedisys, this partnership will help it to progress with respect to the latest and differentiated payment models. Further, Amedisys expects to strengthen partnerships with Managed Care Organizations and drive patient insights required for risk arrangements using the Medalogix platform.

Home Health and Hospice Opportunities Galore

In November 2017, Centers for Medicare and Medicaid Services (CMS) issued a final rule to update and revise the 2018 Medicare home health reimbursement rates without finalizing the Home Health Groupings Model (HHGM), which was proposed to be implemented in 2019. With this, CMS projects a decline of 0.4% in reimbursement to home health providers resulting from the payment provisions of the final rule.

According to home health players like Amedisys, HHGM is one of the most significant regulatory proposals and has the potential to hurt the industry. Amedisys is currently leaving no stone unturned to benefit from this situation. It is striving to improve the quality of care as well as implement disease management programs at hospitals. The company is also working on expanding its business by garnering more referrals from hospitals.

Amedisys also expects to be able to cope up with the ongoing “shift to value” in the healthcare industry by taking the necessary steps. Per management, CMS’ three-pronged strategy aims at enhanced individual patient care, improved health outcomes and cost reduction.

Furthermore, there has been a surge in Medicare Advantage enrollment. Moreover, payors are forming new partnerships that allow patients to receive care in the home. Thus, management believes by combining new technology with home health services, Amedisys might be able to gain an edge over competitors and exploit the increasing opportunities in the niche market.

Market Potential

The home health industry is poised for tremendous growth, courtesy of an aging U.S. population, patients’ desire for independence and home health as a cheaper care modality. The company should continue to benefit from the aging demographics of the U.S. population and the need for higher acuity patients to be taken care of in a home nursing environment.

Going by a report by Grand View Research, the global home healthcare market is expected to see a CAGR of 7.8% between 2014 and 2025.

Share Price Movement

Amedisys has been gaining investor confidence on consistently positive results. Over the past year, the company’s share price has outperformed its industry. The stock has gained 134.5% in comparison with the industry’s 22.8% rise.

Zacks Rank & Other Key Picks

Amedisys currently carries a Zacks Rank #1 (Strong Buy).

A few other top-ranked stocks in the broader medical space are Integer Holdings Corporation ITGR, Intuitive Surgical ISRG and Masimo Corporation MASI.

Integer Holdings’ expected long-term earnings growth rate is 15%. The stock sports a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Intuitive Surgical’s long-term expected earnings growth rate is 14.7%. The stock carries a Zacks Rank #1.

Masimo’s long-term expected earnings growth rate is 14.8%. The stock has a Zacks Rank #2.

5 Companies Verge on Apple-Like Run

Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2018 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs. A bonus Zacks Special Report names this breakthrough and the 5 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains.

Click to see them right now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Integer Holdings Corporation (ITGR) : Free Stock Analysis Report
 
Masimo Corporation (MASI) : Free Stock Analysis Report
 
Intuitive Surgical, Inc. (ISRG) : Free Stock Analysis Report
 
Amedisys, Inc. (AMED) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

  • 7 Stocks to Buy and Hold Through Any Market Selloff
    Business
    InvestorPlace

    7 Stocks to Buy and Hold Through Any Market Selloff

    Last week’s market collapse made headlines throughout the world. Since the sharp correction has negatively impacted virtually all investment sectors, you’re going to find discounted deals everywhere you look.

  • Brits Are All Making the Same Joke About the New Royal Baby
    News
    Time

    Brits Are All Making the Same Joke About the New Royal Baby

    Meghan Markle, the Duchess of Sussex, is expecting her first child with Prince Harry. The news, announced Monday morning by Kensington Palace, has already been greeted by hundreds of messages of congratulations for the royal couple on social media. The U.K. is set to leave the European Union on March 29, exactly two years after Prime Minister Theresa May started the formal process for doing so by invoking Article 50 of the Lisbon Treaty.

  • Netflix is ditching freeloaders from subscriber forecasts after volatile stock moves
    Business
    MarketWatch

    Netflix is ditching freeloaders from subscriber forecasts after volatile stock moves

    After two consecutive quarters of missing the mark on its own forecasts for subscriber growth, Netflix Inc. hopes to put an end to the big swings in its stock with some changes in its accounting. In kicking off tech’s earnings season Tuesday, Netflix (NFLX) reported better-than-expected subscriber growth in the quarter, leading to an 11% jump in its shares in after-hours trading. Three months ago, Netflix reported weaker-than-expected subscriber growth, sending its stock tumbling around 12% in the next trading day.

  • Boeing delivers first 737 Max 8 BBJ and unveils Max 7 luxury interior (Photos)
    Business
    American City Business Journals

    Boeing delivers first 737 Max 8 BBJ and unveils Max 7 luxury interior (Photos)

    Boeing has delivered its very first 737 Max 8 business jet to a paying customer. It's the first of 20 BBJ Max jets that buyers from around the world have ordered from the Chicago-based jetmaker since they went on sale. Boeing spokesman Dmitry Krol declined to identify the buyer of the jet, which is the second of its kind made at Boeing's Renton 737 factory.

  • Marijuana Stocks to Watch in October -- and Into 2019
    Business
    Motley Fool

    Marijuana Stocks to Watch in October -- and Into 2019

    Tomorrow, Wednesday, Oct. 17, Canada will become the first industrialized county in the world where marijuana is legal for adult recreational use -- and only the second country, along with Uruguay, where such use is legal.  Not only does this open up

  • Social Security Checks Are Increasing: What Does That Mean For You?
    Business
    Fortune

    Social Security Checks Are Increasing: What Does That Mean For You?

    Social Security checks will see their biggest increase in four years as 2019 kicks off. The Social Security Administration has approved a 2.8% cost of living adjustment (COLA) for next year. That follows a 2% jump this year and an increase of just

  • General Electric (GE) Stock Sinks As Market Gains: What You Should Know
    Finance
    Zacks

    General Electric (GE) Stock Sinks As Market Gains: What You Should Know

    With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

  • YouTube goes down for more than an hour
    Business
    Associated Press

    YouTube goes down for more than an hour

    YouTube's video streaming service went out for more than an hour on Tuesday, apparently affecting locations around the world. YouTube acknowledged the outage in a tweet at 9:41 p.m. EDT, noting that it affected YouTube, YouTube Music and YouTube TV. Reporters for the AP found that YouTube's main service was working again around 10:50 p.m. EDT.

  • Sears soars 36% — one day after filing for bankruptcy (SHLD)
    Finance
    Business Insider

    Sears soars 36% — one day after filing for bankruptcy (SHLD)

    The retailer received approval on Tuesday to access a $300 million loan to keep it afloat during bankruptcy. Sears Holdings soared as much as 124% — one day after filing for bankruptcy — as the embattled retailer received approval to access a $300 million loan to keep it afloat during bankruptcy.

  • Jamal Khashoggi was accidentally killed during interrogation: report
    World
    Fox Business Videos

    Jamal Khashoggi was accidentally killed during interrogation: report

    Fox Business foreign policy analyst Walid Phares on the report that Saudi journalist Jamal Khashoggi was accidentally killed.

  • Where Will NVIDIA Be in 5 Years?
    Business
    Motley Fool

    Where Will NVIDIA Be in 5 Years?

    At one time, NVIDIA (NASDAQ: NVDA) floated under the radar in the technology sector. Its graphics processing units (GPUs) were then niche tech products that appealed mainly to graphic artists and hardcore PC gamers, but that all changed over the last

  • Why MannKind Corp. Soared 16.4% Tuesday
    Business
    Motley Fool

    Why MannKind Corp. Soared 16.4% Tuesday

    After MannKind Corp. (NASDAQ: MNKD) announced that it closed on its planned collaboration agreement with United Therapeutics (NASDAQ: UTHR), its shares rallied 16.4% on Tuesday. MannKind only has one Food and Drug Administration (FDA)-approved drug to its name, Afrezza, an inhalable insulin. Afrezza was launched in 2015 and sales have been far shy of optimistic pre-launch forecasts.

  • Saudi Arabia using the 'oil weapon option' could cause prices to soar to $150
    World
    Business Insider

    Saudi Arabia using the 'oil weapon option' could cause prices to soar to $150

    Analysts see a 1973-style embargo as unlikely, but warn oil prices could hit triple-digits if tensions escalate. "We believe that Saudi leadership would be extremely reluctant to exercise the oil weapon option, as its reputation as the world’s stable, reliable oil central banker would be severely undercut," RBC analysts wrote in a research note.

  • Call of the day: Tilray as Benchmark starts coverage with bullish rating
    Business
    Yahoo Finance Video

    Call of the day: Tilray as Benchmark starts coverage with bullish rating

    Benchmark initiated its coverage of Tilray with a 'buy' rating and a $200 price target. Analyst Mike Hickey said he's bullish on the cannabis company's early leadership in the medical cannabis market in Canada and its strategic alliance with Novartis.

  • 3 Top Large-Cap Stocks to Buy in October
    Business
    Motley Fool

    3 Top Large-Cap Stocks to Buy in October

    If you're looking for high-quality large-cap stocks to add to your portfolio this month, three of our Motley Fool contributors have some ideas. Here's why you should consider Berkshire Hathaway (NYSE: BRK.B), Cisco Systems (NASDAQ: CSCO), and AT&T (NYSE: T). Tyler Crowe (Berkshire Hathaway): Perhaps one of the most ridiculous investment takes out there right now is that Berkshire Hathaway's immense cash pile isn't a good thing.

  • Walmart is aggressively shifting away from its most legendary shopping format
    Finance
    Yahoo Finance

    Walmart is aggressively shifting away from its most legendary shopping format

    Walmart (WMT) continues to kill off the American shopping creation it’s most known for, the massive supercenter that sells everything under one roof. With the U.S. market already having more than 3,500 Walmart supercenters and a focus by CEO Doug McMillon to increase spending on eCommerce and India, Walmart said Tuesday it will open a mere 10 supercenters in 2019. The company has reduced emphasis on the store format pioneered by founder Sam Walton – which could average a gargantuan 178,000 square feet – in recent years.

  • A Look at AT&T’s Dividends
    Business
    Market Realist

    A Look at AT&T’s Dividends

    What Investors Should Know about AT&T’s Growth Prospects (Continued from Prior Part) Shareholder returns Increasing capital returns to shareholders is one of AT&T’s (T) main priorities. In the second quarter, the company returned $3.1 billion to shareholders

  • Finance
    CNBC

    Morgan Stanley: The stock sell-off is going to get worse

    The stock market is in the middle of a rolling bear market, says Morgan Stanley's Mike Wilson. "It's being caused by a drain in liquidity and peaking growth," Wilson says. The stock market sell-off is only going to get worse, predicts Morgan Stanley's chief U.S. equity strategist, Mike Wilson.

  • These are the bad things about early retirement that no one talks about
    News
    MarketWatch

    These are the bad things about early retirement that no one talks about

    For all the glamour of living an early retirement lifestyle, there are plenty of negatives I’ve come to discover since I permanently left my job in 2012. As a result, you’re repeatedly forced to will yourself into action.

  • Business
    InvestorPlace

    30 Marijuana Stocks to Buy as the Future Turns Green

    With the previous presidential administration’s frankness on the matter, marijuana has become more blasé. Naturally, marijuana stocks have also increased in popularity, where we have more choices today than was previously thought possible. For instance, some of the top marijuana stocks are levered toward medical cannabis.

  • Weed stocks are under pressure on the eve of Canada's legalization (CGC, TLRY)
    Business
    Business Insider

    Weed stocks are under pressure on the eve of Canada's legalization (CGC, TLRY)

    After previously setting record highs, Canopy Growth and Aurora Cannabis had fallen into the red alongside the entire sector. Canada will become the first developed country to legalize recreational cannabis on Wednesday, but with mere hours left before the first sales are legal, many of the largest marijuana stocks were seeing red. Canopy Growth, Aurora Cannabis, and Tilray — collectively the three largest producers by market cap — had all fallen into the red by midday Tuesday, hours after Canopy and Aurora soared to record highs.

  • The Largest Private Employer in the World May Soon Sell Marijuana Products
    Business
    Motley Fool

    The Largest Private Employer in the World May Soon Sell Marijuana Products

    With literally hours remaining, Canada is set to lift the curtain on nine decades of recreational marijuana prohibition tomorrow. This makes Canada the first industrialized country in the world to legalize adult-use weed. As you might rightly imagine, investors can't wait for this legalization to take place.

  • Marijuana stocks to watch: Canopy Growth is the cannabis business’s $4 billion gorilla
    Business
    MarketWatch

    Marijuana stocks to watch: Canopy Growth is the cannabis business’s $4 billion gorilla

    The following article is part of a package of stories that MarketWatch is publishing to mark the start of full legalization of cannabis for adult use in Canada on Wednesday. Smith Falls, Ontario–based Canopy Growth Corp. made headlines and drove cannabis stocks to new heights over the summer when it announced that Corona brewer Constellation Brands Inc. was going to invest an additional $4 billion in the company. Billed by both companies as a strategic partnership, the additional $4 billion investment adds to the 9.9% stake that Constellation bought in October of last year and sets the company up to either be bought outright by Constellation — via warrants that could increase its stake to more than 50% — or continue to work with the beverage company to create a range of consumer-focused cannabis products that may one day appear in markets in dozens of countries.

  • Netflix user growth beats expectations, shares spike
    Finance
    Yahoo Finance

    Netflix user growth beats expectations, shares spike

    Netflix (NFLX) reported user growth that exceeded Wall Street expectations, underscoring a recovery for the online streamer following a rare miss in new user additions last quarter.The Los Gatos, California-based company brought on 6.96 million total new streamers, beating its own guidance of 5 million total member additions for the quarter. The company issued guidance that it would add 9.4 million new members in the fourth quarter of 2018. Netflix’s stock rose 13% in late trading Tuesday.

  • Disney vs Netflix: Here's which stock would have made you richer if you invested $1,000 10 years ago
    Business
    CNBC

    Disney vs Netflix: Here's which stock would have made you richer if you invested $1,000 10 years ago

    On October 16, 1923, Walt and Roy Disney founded The Walt Disney Company and, nearly a century later, the company is one of the largest and most successful media conglomerates in the world. The answer is Netflix. According to CNBC calculations, a $1,000 investment in Netflix in October 2008 would be worth more than $97,560 as of after the earning bell on Monday, or more than 96 times as much, including price appreciation and dividends reinvested.